RETA logo

Reata Pharmaceuticals (RETA) EBIT

Annual EBIT

-$270.15 M
-$25.57 M-10.45%

December 31, 2022

Summary

Performance

1-Year Change

-10.45%

3-Year Change

+3.16%

5-Year Change

-484.57%

15-Year Change

-484.57%

RETA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.63 M
RETA annual earnings before interest & taxes is currently -7552.55% below its historical high of $3.63 million

3-Year Low

-$270.15 M
RETA annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
RETA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
RETA next annual earnings announcement has not yet been scheduled

OtherRETAprofitabilitymetrics:

Annual Revenue

$2.22 M
RETA annual revenue is $2.22 million

Annual Net Income

-$311.90 M
RETA annual net profit is -$311.90 million

Annual EBITDA

-$269.02 M
RETA annual EBITDA is -$269.02 million

Annual EPS

-$8.54
RETA annual earnings per share is -$8.54

Quarterly EBIT

$200.97 M
+$306.07 M+291.22%

June 30, 2023

Summary

Performance

3-Month Change

+291.22%

1-Year Change

+417.6%

3-Year Change

+427.98%

5-Year Change

+836.1%

RETA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$200.97 M
RETA quarterly earnings before interest & taxes is currently at an all-time high

3-Year Low

-$105.10 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
RETA previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
RETA next earnings announcement has not yet been scheduled

OtherRETAprofitabilitymetrics:

Quarterly Revenue

$22.75 M
RETA quarterly revenue is $22.75 million

Quarterly Net Income

$193.00 M
RETA quarterly net profit is $193.00 million

Quarterly EBITDA

$201.26 M
RETA quarterly EBITDA is $201.26 million

Quarterly EPS

$4.65
RETA quarterly earnings per share is $4.65

TTM EBIT

-$47.06 M
+$264.25 M+84.88%

June 30, 2023

Summary

Performance

3-Month Change

+84.88%

1-Year Change

+81.67%

3-Year Change

+86.43%

5-Year Change

+83.13%

RETA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$223.00 K
RETA TTM earnings before interest & taxes is currently <-9900.00% below its historical high of $223.00 thousand

3-Year Low

-$311.31 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
RETA previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
RETA next earnings announcement has not yet been scheduled

OtherRETAprofitabilitymetrics:

TTM Revenue

$23.48 M
RETA TTM revenue is $23.48 million

TTM Net Income

-$87.62 M
RETA TTM net profit is -$87.62 million

TTM EBITDA

-$45.94 M
RETA TTM EBITDA is -$45.94 million

TTM EPS

-$2.98
RETA TTM earnings per share is -$2.98

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$270.15 M
RETA annual earnings before interest & taxes is -$270.15 million

Annual Revenue

$2.22 M
RETA annual revenue is $2.22 million

Annual Cost Of Goods Sold

-
RETA annual cost of goods sold value is unknown

Annual Operating Expenses

$280.25 M
RETA annual total operating expenses is $280.25 million

RETA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.4%+417.6%+81.7%
3 y3 years+3.2%+428.0%+86.4%
5 y5 years-484.6%+836.1%+83.1%

RETA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+10.5%at lowat high-152.3%at high+561.5%
5 y5-year+15.7%+3.3%at high-191.1%at high+671.4%
alltimeall time-7552.6%+3.3%at high-191.1%<-9999.0%+671.4%

Reata Pharmaceuticals EBIT History

DateAnnualQuarterlyTTM
Jun 2023
-
$200.97 M(-291.2%)
-$47.06 M(-84.9%)
Mar 2023
-
-$105.10 M(+40.9%)
-$311.31 M(+15.2%)
Dec 2022
-$270.15 M(+10.5%)
-$74.60 M(+9.2%)
-$270.15 M(+1.1%)
Sep 2022
-
-$68.34 M(+8.0%)
-$267.11 M(+4.0%)
Jun 2022
-
-$63.28 M(-1.0%)
-$256.82 M(+1.2%)
Mar 2022
-
-$63.94 M(-10.6%)
-$253.69 M(+3.7%)
Dec 2021
-$244.59 M(+4.8%)
-$71.55 M(+23.2%)
-$244.58 M(+8.0%)
Sep 2021
-
-$58.05 M(-3.5%)
-$226.44 M(+2.1%)
Jun 2021
-
-$60.15 M(+9.7%)
-$221.85 M(-0.5%)
Mar 2021
-
-$54.83 M(+2.7%)
-$222.98 M(-4.5%)
Dec 2020
-$233.46 M(-16.3%)
-$53.41 M(-0.1%)
-$233.46 M(-35.7%)
Sep 2020
-
-$53.47 M(-12.7%)
-$363.05 M(+4.7%)
Jun 2020
-
-$61.28 M(-6.2%)
-$346.85 M(+9.2%)
Mar 2020
-
-$65.31 M(-64.3%)
-$317.52 M(+13.8%)
Dec 2019
-$278.96 M(+275.2%)
-$183.00 M(+391.0%)
-$278.96 M(+134.2%)
Sep 2019
-
-$37.27 M(+16.7%)
-$119.14 M(+8.0%)
Jun 2019
-
-$31.95 M(+19.4%)
-$110.34 M(+4.4%)
Mar 2019
-
-$26.75 M(+15.5%)
-$105.69 M(+42.2%)
DateAnnualQuarterlyTTM
Dec 2018
-$74.34 M(+60.9%)
-$23.17 M(-18.6%)
-$74.35 M(+10.4%)
Sep 2018
-
-$28.47 M(+4.3%)
-$67.36 M(+32.8%)
Jun 2018
-
-$27.30 M(-694.7%)
-$50.71 M(+46.9%)
Mar 2018
-
$4.59 M(-128.4%)
-$34.53 M(-25.3%)
Dec 2017
-$46.21 M(+593.1%)
-$16.18 M(+36.8%)
-$46.22 M(+35.2%)
Sep 2017
-
-$11.82 M(+6.3%)
-$34.17 M(+47.0%)
Jun 2017
-
-$11.12 M(+56.8%)
-$23.25 M(+71.9%)
Mar 2017
-
-$7.09 M(+71.5%)
-$13.52 M(+102.8%)
Dec 2016
-$6.67 M(+1896.4%)
-$4.13 M(+361.5%)
-$6.67 M(+115.5%)
Sep 2016
-
-$896.00 K(-35.9%)
-$3.09 M(+80.5%)
Jun 2016
-
-$1.40 M(+482.1%)
-$1.71 M(+11.4%)
Mar 2016
-
-$240.00 K(-57.2%)
-$1.54 M(+360.5%)
Dec 2015
-$334.00 K(-109.2%)
-$561.00 K(-215.9%)
-$334.00 K(-35.0%)
Sep 2015
-
$484.00 K(-139.6%)
-$514.00 K(-48.5%)
Jun 2015
-
-$1.22 M(-226.7%)
-$998.00 K(-547.5%)
Mar 2015
-
$964.00 K(-230.1%)
$223.00 K(-130.1%)
Dec 2014
$3.63 M(-134.9%)
-$741.00 K
-$741.00 K
Dec 2013
-$10.38 M
-
-

FAQ

  • What is Reata Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals annual EBIT year-on-year change?
  • What is Reata Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Reata Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Reata Pharmaceuticals?
  • What is Reata Pharmaceuticals TTM EBIT year-on-year change?

What is Reata Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of RETA is -$270.15 M

What is the all time high annual EBIT for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high annual earnings before interest & taxes is $3.63 M

What is Reata Pharmaceuticals annual EBIT year-on-year change?

Over the past year, RETA annual earnings before interest & taxes has changed by -$25.57 M (-10.45%)

What is Reata Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of RETA is $200.97 M

What is the all time high quarterly EBIT for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high quarterly earnings before interest & taxes is $200.97 M

What is Reata Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, RETA quarterly earnings before interest & taxes has changed by +$264.25 M (+417.60%)

What is Reata Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of RETA is -$47.06 M

What is the all time high TTM EBIT for Reata Pharmaceuticals?

Reata Pharmaceuticals all-time high TTM earnings before interest & taxes is $223.00 K

What is Reata Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, RETA TTM earnings before interest & taxes has changed by +$209.76 M (+81.67%)